Gene · 2012
EMP1: epithelial membrane protein 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. EMP1: epithelial membrane protein 1. Genes, record 2012. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2012
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P54849 | Epithelial membrane protein 1 | 157 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents53
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 45124 | P54849 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1611 | P54849 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 63 | P54849 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1389 | P54849 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1389 | P54849 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1611 | P54849 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 63 | P54849 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 27764 | P54849 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 2368 | P54849 | Espacenet |
| JP 2022092366 A | 2022-06-22 | 479 | P54849 | Espacenet |
1 to 10 of 53
See all 53 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants841
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | EMP1 papers | Newest fiscal year |
|---|---|---|---|
| P30ES013508 | Center of Excellence in Environmental Toxicology | 7 | 2025 |
| R01ES029294 | Metabolic activation of nitroarenes and Nrf2-Keap1 | 6 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 5 | 2025 |
| ZIALM200887 | Algorithmic approaches to systems biology, data integration, and evolution | 5 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 4 | 2025 |
| P01CA108671 | Myeloproliferative Neoplasms-Research Consortium | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 841Source NIH's project files
See all 841 nih grantsPapers1,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Substituent‑controlled energy‑sensitivity trade‑off in (E)-1,2-bis(tetrazolo[1,5-d][1,2,3,4]tetrazin-7(1H)-yl)diazene derivatives. | J Mol Model | 2026 | 42776264 | PubTator, text mining | PubMed |
| The Anisotropic Response and Initial Reaction Mechanism of a CL-20/MTNP High-Energy Cocrystal under Impact Loading. | ACS Omega | 2026 | 42730066 | PubTator, text mining | PubMed |
| Generalizable 3'-Hydroxyl-Regenerating Primer Platform for Photoactivatable DNA Polymerase Regulation in Nucleic Acid Amplification. | Anal Chem | 2026 | 42689565 | PubTator, text mining | PubMed |
| Physical Responses to the Structural Evolution of CL-20-Based Energetic Solvates with H2O2 and H2O Under External Electric Field. | Int J Mol Sci | 2026 | 42653214 | PubTator, text mining | PubMed |
| Pseudomorphic Replacement Driven Construction of Hierarchical Homostructured CL-20 Core-Shell Architectures for Safety Improvement. | Small | 2026 | 42522771 | PubTator, text mining | PubMed |
| Effect of Precompression on Detonation Performance and Products of Energetic Materials: Application to CL-20. | J Phys Chem C Nanomater Interfaces | 2026 | 42416200 | PubTator, text mining | PubMed |
| Correction: Expression analysis of epithelial membrane protein 1 (EMP1) gene in kidney stone patients. | Int Urol Nephrol | 2026 | 42405990 | PubTator, text mining | PubMed |
| Bridging local-global transmembrane protein contexts with contrastive pretraining for alignment-free pathogenicity prediction. | Brief Bioinform | 2026 | 42398071 | PubTator, text mining | PubMed |
| A Novel CAF-Related Signature for Precise Prediction of Clinical Outcomes and Immunotherapy Response for Breast Cancer Patients: Based on Multiomics Analyses and Experimental Validation. | Mediators Inflamm | 2026 | 42359574 | PubTator, text mining | PubMed |
| Preconditioning with sufentanil confers protective effects in transplantation by attenuating hepatic ischemia-reperfusion injury. | World J Transplant | 2026 | 42281863 | PubTator, text mining | PubMed |
1 to 10 of 1,540
See all 1,540 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2012
GET https://conductscience.org/api/genes/v1/2012/patents?page=2